New patent for Actelion drug UPTRAVI

   December 10, 2021    Comments Off on New patent for Actelion drug UPTRAVI    Posted in: Patent Added

Annual Drug Patent Expirations for UPTRAVI Uptravi is a drug marketed by Actelion and is included in two NDAs. It is available from one supplier. There are six patents protecting…

The post New patent for Actelion drug UPTRAVI appeared first on DrugPatentWatch - Make Better Decisions.

  

Comments are closed.

Biotechblog